Octozi Joins Debiopharm Innovation Fund's Portfolio
Deal News | Jun 10, 2025 | Debiopharm Innovation Fund
Debiopharm Innovation Fund has added Octozi to its investment portfolio. This strategic move indicates Debiopharm's commitment to strengthening its investment holdings. Octozi's inclusion is expected to enhance innovation and provide growth opportunities in their respective fields.
Sectors
- Private Equity & Venture Capital
- Healthcare & Pharmaceuticals
Geography
- Switzerland – Debiopharm Innovation Fund is based in Switzerland, indicating its geographic influence in this investment.
Industry
- Private Equity & Venture Capital – Debiopharm Innovation Fund operates within the private equity and venture capital industry, investing in companies like Octozi.
- Healthcare & Pharmaceuticals – The investment aligns with Debiopharm's focus on healthcare and pharmaceutical innovation.
Financials
- Not disclosed – The financial terms of the investment or acquisition were not disclosed in the article.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Debiopharm Innovation Fund | Bidding Company | Company | A Switzerland-based private equity and venture capital fund focusing on healthcare and pharmaceutical innovations. |
| Octozi | Target Company | Company | A company that has been added to Debiopharm Innovation Fund's investment portfolio. |